$1.46
Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Dogwood Therapeutics Enrolls First 200 Patients in Phase 2b Neuropathic Pain Trial
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
Overview
52-week range
$1.28
$9.50
2% of range
Avg surprise (last 3)
-157.6%
Avg reaction (last 2)
+2.5%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.15 | $-0.22 | +31.8% | +96.4% | +6.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-8.20 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-1.99 | $-1.26 | -57.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-4.21 | $-0.77 | -446.8% | — | -1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.05 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.15 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.68 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.62 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.13 | -$1.99 | +93.5% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | — | $-16M | $-4M | $-4M | — | $-2M | $-1M |
| Net income | $-5M | — | $-16M | $-4M | $-11M | — | $-2M | $-1M |
| EPS (diluted) | $-0.15 | — | $-8.20 | $-1.99 | $-8.45 | — | $-2.05 | $-1.15 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $13M | $7M | $10M | $13M | $18M | $15M | $2M | $3M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $15M | $8M | $12M | $15M | $19M | $17M | $2M | $4M |
| Total assets | $95M | $90M | $92M | $97M | $97M | $94M | $2M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $15M | $15M | $15M | $14M | $14M | $30M | $1M | $500,076 |
| Total equity | $81M | $75M | $7M | $7M | $7M | $-10M | $949,431 | $3M |
Implied volatility — last 90 days
No IV snapshots yet for DWTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.